of the study; Percentage of men taking the drugs who developed prostate cancer compared to the percentage of men who did not take the medication; Suggestion that the drugs block the action of an enzyme that triggers the production of prostaglandins thought to be associated with the cancer.Scott...
commoncancerin men and in people assigned male a birth. About 1 in 8 will be diagnosed with prostate cancer in their lifetime. And these are just the ones who are diagnosed. Among very elderly men who die of other causes, a surprising two-thirds may have prostate cancer that was never ...
Accordingly, younger men with stage I-II colorectal cancers at diagnosis (or stage III colorectal cancer that has not recurred 5 years after treatment) who have no or minimal comorbidities and who are at increased risk for either a diagnosis of prostate cancer or mortality secondary to prostate...
Home to the journal Oncology, Cancer Network provides research and opinion on the screening, early detection, diagnosis, treatment, and prevention of cancers.
Prostate cancer (PCa) is the second most frequently diagnosed cancer in men worldwide1. Radical prostatectomy has undergone advances during the past 100 years. Walsh distinguished the locations of neurovascular bundles (NVBs) in relation to the fascial planes around the prostate, and hence the modi...
We sought to assess this effect, while limiting competing causes of death, through the examination of a younger PCa patient cohort within the National Cancer Database. Methods: We evaluated the overall survival (OS) of men under 60 with high risk PCa receiving either radiation therapy (RT) or...
Treatment of these men results in harms and provides them with no benefit. This is known as overdiagnosis, and follow-up of large randomized trials suggests that 20% to 50% of men diagnosed with prostate cancer through screening may be overdiagnosed.3 Overdiagnosis rates would be expected to ...
and Ovarian (PLCO) Cancer Screening Trial uses actuarial analysis to analyze the association of baseline PSA levels with long-term risk of any prostate cancer and of clinically significant prostate cancer among men aged 55 to 60 years enrolled in the screening group of the trial between 1993 and...
including rapid autopsy specimens from men who failed contemporary therapies. This resource provides an opportunity to link the molecular changes in prostate cancer to pathology; grow organoids; and test functional responses to therapies, which have rarely been applied to prostate cancer given the lack...
Prostate cancer Diagnosis Prostate-specific antigen Percent free PSA Chinese population ROC curve 1. Introduction Prostate cancer (PCa) is the second-most frequently diagnosed malignancy in men globally [1]. Although the incidence of PCa in China is much lower than in Western countries [2], PCa ...